1887

Abstract

Matrix metalloproteinases (MMPs) degrade extracellular matrix. They are involved in cellular proliferation, migration, angiogenesis, invasion and metastasis. MT-1 MMP, a membrane-bound MMP, is expressed in carcinomas of the uterine cervix . This type of cancer is associated with human papillomavirus (HPV) infection. Here it was shown that keratinocytes transformed with HPV16 or HPV18 , and HPV-positive cervical carcinoma cell lines, constitutively expressed MT-1 MMP. Expression of the E7 protein from the mucosal and cutaneous high-risk types HPV16 and HPV8, but not from the cutaneous low-risk type HPV1, was sufficient to induce MT-1 MMP expression in primary human keratinocytes and HaCaT cells. As a consequence, MMP-2 was activated. MT-1 MMP expression might play a role in the HPV life cycle by promoting proliferation of host cells and might contribute to their invasive phenotype during malignant progression.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.80551-0
2005-05-01
2019-10-20
Loading full text...

Full text loading...

/deliver/fulltext/jgv/86/5/vir861291.html?itemId=/content/journal/jgv/10.1099/vir.0.80551-0&mimeType=html&fmt=ahah

References

  1. Aaronson, S. A., Rubin, J. S., Finch, P. W., Wong, J., Marchese, C., Falco, J., Taylor, W. G. & Kraus, M. H. ( 1990; ). Growth factor-regulated pathways in epithelial cell proliferation. Am Rev Respir Dis 142, S7–S10.[CrossRef]
    [Google Scholar]
  2. Azzam, H. S., Arand, G., Lippman, M. E. & Thompson, E. W. ( 1993; ). Association of MMP-2 activation potential with metastatic progression in human breast cancer cell lines independent of MMP-2 production. J Natl Cancer Inst 85, 1758–1764.[CrossRef]
    [Google Scholar]
  3. Balbin, M., Fueyo, A., Tester, A. M., Pendas, A. M., Pitiot, A. S., Astudillo, A., Overall, C. M., Shapiro, S. D. & Lopez-Otin, C. ( 2003; ). Loss of collagenase-2 confers increased skin tumor susceptibility to male mice. Nat Genet 35, 252–257.[CrossRef]
    [Google Scholar]
  4. Boukamp, P., Petrussevska, R. T., Breitkreutz, D., Hornung, J., Markham, A. & Fusenig, N. E. ( 1988; ). Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol 106, 761–771.[CrossRef]
    [Google Scholar]
  5. Brummer, O., Bohmer, G., Hollwitz, B., Flemming, P., Petry, K. U. & Kuhnle, H. ( 2002; ). MMP-1 and MMP-2 in the cervix uteri in different steps of malignant transformation – an immunohistochemical study. Gynecol Oncol 84, 222–227.[CrossRef]
    [Google Scholar]
  6. Butler, G. S., Butler, M. J., Atkinson, S. J. & 7 other authors ( 1998; ). The TIMP2 membrane type 1 metalloproteinase “receptor” regulates the concentration and efficient activation of progelatinase A. A kinetic study. J Biol Chem 273, 871–880.[CrossRef]
    [Google Scholar]
  7. Chattopadhyay, N., Mitra, A., Frei, E. & Chatterjee, A. ( 2001; ). Human cervical tumor cell (SiHa) surface αvβ3 integrin receptor has associated matrix metalloproteinase (MMP-2) activity. J Cancer Res Clin Oncol 127, 653–658.[CrossRef]
    [Google Scholar]
  8. Coussens, L. M., Tinkle, C. L., Hanahan, D. & Werb, Z. ( 2000; ). MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell 103, 481–490.[CrossRef]
    [Google Scholar]
  9. Davidson, B., Goldberg, I., Kopolovic, J., Lerner-Geva, L., Gotlieb, W. H., Ben-Baruch, G. & Reich, R. ( 1999; ). MMP-2 and TIMP-2 expression correlates with poor prognosis in cervical carcinoma – a clinicopathologic study using immunohistochemistry and mRNA in situ hybridization. Gynecol Oncol 73, 372–382.[CrossRef]
    [Google Scholar]
  10. Dobbs, S. P., Hewett, P. W., Johnson, I. R., Carmichael, J. & Murray, J. C. ( 1997; ). Angiogenesis is associated with vascular endothelial growth factor expression in cervical intraepithelial neoplasia. Br J Cancer 76, 1410–1415.[CrossRef]
    [Google Scholar]
  11. Durst, M., Dzarlieva-Petrusevska, R. T., Boukamp, P., Fusenig, N. E. & Gissmann, L. ( 1987; ). Molecular and cytogenetic analysis of immortalized human primary keratinocytes obtained after transfection with human papillomavirus type 16 DNA. Oncogene 1, 251–256.
    [Google Scholar]
  12. Feltkamp, M. C., Broer, R., di Summa, F. M. & 7 other authors ( 2003; ). Seroreactivity to epidermodysplasia verruciformis-related human papillomavirus types is associated with nonmelanoma skin cancer. Cancer Res 63, 2695–2700.
    [Google Scholar]
  13. Fuchs, P. G. & Pfister, H. ( 1996; ). Papillomaviruses in epidermodysplasia verruciformis. In Papillomavirus Reviews: Current Research on Papillomaviruses, pp. 253–262. Edited by C. Lacey. Leeds: Leeds University Press.
  14. Gaiotto, M. A., Focchi, J., Ribalta, J. L., Stavale, J. N., Baracat, E. C., Lima, G. R. & Guerreiro da Silva, I. D. ( 2004; ). Comparative study of MMP-2 (matrix metalloproteinase 2) immune expression in normal uterine cervix, intraepithelial neoplasias, and squamous cells cervical carcinoma. Am J Obstet Gynecol 190, 1278–1282.[CrossRef]
    [Google Scholar]
  15. Gilles, C., Polette, M., Piette, J., Munaut, C., Thompson, E. W., Birembaut, P. & Foidart, J. M. ( 1996; ). High level of MT-MMP expression is associated with invasiveness of cervical cancer cells. Int J Cancer 65, 209–213.[CrossRef]
    [Google Scholar]
  16. Goldberg, G. I., Marmer, B. L., Grant, G. A., Eisen, A. Z., Wilhelm, S. & He, C. S. ( 1989; ). Human 72-kilodalton type IV collagenase forms a complex with a tissue inhibitor of metalloproteases designated TIMP-2. Proc Natl Acad Sci U S A 86, 8207–8211.[CrossRef]
    [Google Scholar]
  17. Guidi, A. J., Abu-Jawdeh, G., Berse, B., Jackman, R. W., Tognazzi, K., Dvorak, H. F. & Brown, L. F. ( 1995; ). Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in cervical neoplasia. J Natl Cancer Inst 87, 1237–1245.[CrossRef]
    [Google Scholar]
  18. Hernandez-Barrantes, S., Bernardo, M., Toth, M. & Fridman, R. ( 2002; ). Regulation of membrane type-matrix metalloproteinases. Semin Cancer Biol 12, 131–138.[CrossRef]
    [Google Scholar]
  19. Howes, K. A., Ransom, N., Papermaster, D. S., Lasudry, J. G., Albert, D. M. & Windle, J. J. ( 1994; ). Apoptosis or retinoblastoma: alternative fates of photoreceptors expressing the HPV-16 E7 gene in the presence or absence of p53 [published erratum appears in Genes Dev 8, 1738, 1994]. Genes Dev 8, 1300–1310.[CrossRef]
    [Google Scholar]
  20. Iftner, T., Bierfelder, S., Csapo, Z. & Pfister, H. ( 1988; ). Involvement of human papillomavirus type 8 genes E6 and E7 in transformation and replication. J Virol 62, 3655–3661.
    [Google Scholar]
  21. Itoh, Y., Takamura, A., Ito, N., Maru, Y., Sato, H., Suenaga, N., Aoki, T. & Seiki, M. ( 2001; ). Homophilic complex formation of MT1-MMP facilitates proMMP-2 activation on the cell surface and promotes tumor cell invasion. EMBO J 20, 4782–4793.[CrossRef]
    [Google Scholar]
  22. Kabsch, K. & Alonso, A. ( 2002; ). The human papillomavirus type 16 E5 protein impairs TRAIL- and FasL-mediated apoptosis in HaCaT cells by different mechanisms. J Virol 76, 12162–12172.[CrossRef]
    [Google Scholar]
  23. Kajita, M., Itoh, Y., Chiba, T., Mori, H., Okada, A., Kinoh, H. & Seiki, M. ( 2001; ). Membrane-type 1 matrix metalloproteinase cleaves CD44 and promotes cell migration. J Cell Biol 153, 893–904.[CrossRef]
    [Google Scholar]
  24. Koshikawa, N., Giannelli, G., Cirulli, V., Miyazaki, K. & Quaranta, V. ( 2000; ). Role of cell surface metalloprotease MT1-MMP in epithelial cell migration over laminin-5. J Cell Biol 148, 615–624.[CrossRef]
    [Google Scholar]
  25. Lara-Pezzi, E., Gomez-Gaviro, M. V., Galvez, B. G., Mira, E., Iniguez, M. A., Fresno, M., Martinez, A. C., Arroyo, A. G. & Lopez-Cabrera, M. ( 2002; ). The hepatitis B virus X protein promotes tumor cell invasion by inducing membrane-type matrix metalloproteinase-1 and cyclooxygenase-2 expression. J Clin Invest 110, 1831–1838.[CrossRef]
    [Google Scholar]
  26. Lehman, T. A., Modali, R., Boukamp, P. & 7 other authors ( 1993; ). p53 mutations in human immortalized epithelial cell lines. Carcinogenesis 14, 833–839.[CrossRef]
    [Google Scholar]
  27. Liotta, L. A., Tryggvason, K., Garbisa, S., Hart, I., Foltz, C. M. & Shafie, S. ( 1980; ). Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature 284, 67–68.[CrossRef]
    [Google Scholar]
  28. Magal, S. S., Jackman, A., Pei, X. F., Schlegel, R. & Sherman, L. ( 1998; ). Induction of apoptosis in human keratinocytes containing mutated p53 alleles and its inhibition by both the E6 and E7 oncoproteins. Int J Cancer 75, 96–104.[CrossRef]
    [Google Scholar]
  29. Masini, C., Fuchs, P. G., Gabrielli, F. & 11 other authors ( 2003; ). Evidence for the association of human papillomavirus infection and cutaneous squamous cell carcinoma in immunocompetent individuals. Arch Dermatol 139, 890–894.
    [Google Scholar]
  30. Matthews, K., Leong, C. M., Baxter, L., Inglis, E., Yun, K., Backstrom, B. T., Doorbar, J. & Hibma, M. ( 2003; ). Depletion of Langerhans cells in human papillomavirus type 16-infected skin is associated with E6-mediated down regulation of E-cadherin. J Virol 77, 8378–8385.[CrossRef]
    [Google Scholar]
  31. Mitra, A., Chakrabarti, J., Chattopadhyay, N. & Chatterjee, A. ( 2003; ). Membrane-associated MMP-2 in human cervical cancer. J Environ Pathol Toxicol Oncol 22, 93–100.
    [Google Scholar]
  32. Nuovo, G. J., MacConnell, P. B., Simsir, A., Valea, F. & French, D. L. ( 1995; ). Correlation of the in situ detection of polymerase chain reaction-amplified metalloproteinase complementary DNAs and their inhibitors with prognosis in cervical carcinoma. Cancer Res 55, 267–275.
    [Google Scholar]
  33. Obermair, A., Bancher-Todesca, D., Bilgi, S., Kaider, A., Kohlberger, P., Mullauer-Ertl, S., Leodolter, S. & Gitsch, G. ( 1997; ). Correlation of vascular endothelial growth factor expression and microvessel density in cervical intraepithelial neoplasia. J Natl Cancer Inst 89, 1212–1217.[CrossRef]
    [Google Scholar]
  34. Okada, A., Bellocq, J. P., Rouyer, N., Chenard, M. P., Rio, M. C., Chambon, P. & Basset, P. ( 1995; ). Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas. Proc Natl Acad Sci U S A 92, 2730–2734.[CrossRef]
    [Google Scholar]
  35. Pei, D. & Weiss, S. J. ( 1995; ). Furin-dependent intracellular activation of the human stromelysin-3 zymogen. Nature 375, 244–247.[CrossRef]
    [Google Scholar]
  36. Remacle-Bonnet, M. M., Garrouste, F. L. & Pommier, G. J. ( 1997; ). Surface-bound plasmin induces selective proteolysis of insulin-like-growth-factor (IGF)-binding protein-4 (IGFBP-4) and promotes autocrine IGF-II bio-availability in human colon-carcinoma cells. Int J Cancer 72, 835–843.[CrossRef]
    [Google Scholar]
  37. Ries, C. & Petrides, P. E. ( 1995; ). Cytokine regulation of matrix metalloproteinase activity and its regulatory dysfunction in disease. Biol Chem Hoppe-Seyler 376, 345–355.
    [Google Scholar]
  38. Sabeh, F., Ota, I., Holmbeck, K. & 10 other authors ( 2004; ). Tumor cell traffic through the extracellular matrix is controlled by the membrane-anchored collagenase MT1-MMP. J Cell Biol 167, 769–781.[CrossRef]
    [Google Scholar]
  39. Sato, H., Takino, T., Okada, Y., Cao, J., Shinagawa, A., Yamamoto, E. & Seiki, M. ( 1994; ). A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 370, 61–65.[CrossRef]
    [Google Scholar]
  40. Sato, H., Takino, T., Kinoshita, T., Imai, K., Okada, Y., Stetler Stevenson, W. G. & Seiki, M. ( 1996; ). Cell surface binding and activation of gelatinase A induced by expression of membrane-type-1-matrix metalloproteinase (MT1-MMP). FEBS Lett 385, 238–240.[CrossRef]
    [Google Scholar]
  41. Seiki, M., Mori, H., Kajita, M., Uekita, T. & Itoh, Y. ( 2003; ). Membrane-type 1 matrix metalloproteinase and cell migration. Biochem Soc Symp 70, 253–262.
    [Google Scholar]
  42. Sheu, B.-C., Lien, H.-C., Ho, H.-N., Lin, H.-H., Chow, S.-N., Huang, S.-C. & Hsu, S.-M. ( 2003; ). Increased expression and activation of gelatinolytic matrix metalloproteinases is associated with the progression and recurrence of human cervical cancer. Cancer Res 63, 6537–6542.
    [Google Scholar]
  43. Smith-McCune, K., Zhu, Y. H., Hanahan, D. & Arbeit, J. ( 1997; ). Cross-species comparison of angiogenesis during the premalignant stages of squamous carcinogenesis in the human cervix and K14-HPV16 transgenic mice. Cancer Res 57, 1294–1300.
    [Google Scholar]
  44. Smola-Hess, S., Schnitzler, R., Hadaschik, D., Smola, H., Mauch, C., Krieg, T. & Pfister, H. ( 2001; ). CD40L induces matrix-metalloproteinase-9 but not tissue inhibitor of metalloproteinases-1 in cervical carcinoma cells: imbalance between NF-κB and STAT3 activation. Exp Cell Res 267, 205–215.[CrossRef]
    [Google Scholar]
  45. Sounni, N. E., Devy, L., Hajitou, A. & 7 other authors ( 2002; ). MT1-MMP expression promotes tumor growth and angiogenesis through an up-regulation of vascular endothelial growth factor expression. FASEB J 16, 555–564.[CrossRef]
    [Google Scholar]
  46. Sternlicht, M. D. & Werb, Z. ( 2001; ). How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 17, 463–516.[CrossRef]
    [Google Scholar]
  47. Strongin, A. Y., Collier, I., Bannikov, G., Marmer, B. L., Grant, G. A. & Goldberg, G. I. ( 1995; ). Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease. J Biol Chem 270, 5331–5338.[CrossRef]
    [Google Scholar]
  48. Tam, E. M., Morrison, C. J., Wu, Y. I., Stack, M. S. & Overall, C. M. ( 2004; ). Membrane protease proteomics: isotope-coded affinity tag MS identification of undescribed MT1-matrix metalloproteinase substrates. Proc Natl Acad Sci U S A 101, 6917–6922.[CrossRef]
    [Google Scholar]
  49. Thathiah, A. & Carson, D. D. ( 2004; ). MT1-MMP mediates MUC1 shedding independently of TACE/ADAM17. Biochem J 382, 363–373.[CrossRef]
    [Google Scholar]
  50. Walboomers, J. M., Jacobs, M. V., Manos, M. M. & 7 other authors ( 1999; ). Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189, 12–19.[CrossRef]
    [Google Scholar]
  51. zur Hausen, H. ( 2002; ). Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2, 342–350.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.80551-0
Loading
/content/journal/jgv/10.1099/vir.0.80551-0
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error